March 16, 2009 [Taoyuan, Taiwan]: Scandinavian Health Ltd. (SHL) has just received the distinguished red dot award: product design 2009 for the SHL designed and developed Precision Pen Injector (PPI).

The red dot is a worldwide symbol of design and quality, assessed by an international jury of renowned design experts. They examine and test the products and assess them according to criteria such as degree of innovation, functionality, ergonomics, longevity, ecological compatibility and clarity of function. The award is popular and competitive, with only 10% of all entries receiving an award, providing a good indicator of the commercial potential of the product. Earning a place among the top product designs of 2009, the PPI emerged as a winner from a group of over 3,200 entries from 49 countries and will be displayed in the red dot museum.

Jochen Ratjen, SHL’s Chief Industrial Designer for the PPI project, said, "As a company, we have been excited about the mechanical and aesthetical design of this product. We were confident that this would be recognized at some stage and are delighted it came so early and from such a prestigious design competition.”

The PPI is designed to deliver small but highly accurate doses of Restylane Vital™ Light, a treatment for rejuvenating delicate skin, produced by Swedish biomedical firm Q-Med AB. The innovative device was praised by doctors and clinicians during the recent launch at IMCAS, Paris for its ease-of-use and compact design.

Commenting on what this means for the company, Steven Kaufman, Marketing Director said, “Winning a red dot award is an honor for everyone here at SHL and is representative of SHL’s commitment to innovation. We continue to focus on the needs of patients and expand our growing pipeline of intuitive products with improved functionality and design.”

About SHL

SHL is the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices. We have over 1,500 staff globally (1000 staff in Taiwan), with our primary design centers located in the USA and Sweden and manufacturing centers located in Asia.

SHL supplies auto injectors, pen injectors and inhaler systems to global pharmaceutical and biotech companies. Significant investment in R&D has enhanced our broad pipeline of “next generation” drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities.

Our organization consists of three distinct group companies:

SHL Medical
Designs, develops and manufactures advanced drug delivery devices for leading pharmaceutical and biotech companies

SHL Healthcare
Develops and manufactures equipment solutions for home, hospital and long term care use

SHL Technologies
Provides contract manufacturing and engineering services for the production of complex medtech and industrial products

For additional information visit www.shl-group.com or contact us at This e-mail address is being protected from spambots. You need JavaScript enabled to view it